| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cocaine | 15 | 2021 | 81 | 3.460 |
Why?
|
| Receptors, Dopamine D1 | 17 | 2017 | 34 | 3.410 |
Why?
|
| Receptors, Dopamine D3 | 11 | 2017 | 18 | 2.450 |
Why?
|
| Cocaine-Related Disorders | 6 | 2021 | 41 | 1.490 |
Why?
|
| Oocytes | 6 | 2012 | 227 | 1.380 |
Why?
|
| Dopamine Uptake Inhibitors | 6 | 2021 | 44 | 1.280 |
Why?
|
| Ovarian Follicle | 7 | 2014 | 70 | 0.960 |
Why?
|
| Nucleus Accumbens | 10 | 2021 | 113 | 0.960 |
Why?
|
| Cryopreservation | 5 | 2011 | 72 | 0.820 |
Why?
|
| Memory | 3 | 2014 | 229 | 0.790 |
Why?
|
| Mice | 51 | 2021 | 12537 | 0.780 |
Why?
|
| Receptors, Dopamine D2 | 7 | 2015 | 57 | 0.680 |
Why?
|
| Corpus Striatum | 4 | 2017 | 92 | 0.640 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 2010 | 90 | 0.640 |
Why?
|
| Mice, Mutant Strains | 13 | 2010 | 232 | 0.610 |
Why?
|
| Proto-Oncogene Proteins c-fos | 5 | 2017 | 67 | 0.600 |
Why?
|
| Animals | 54 | 2021 | 28891 | 0.580 |
Why?
|
| Dopamine Agents | 2 | 2017 | 32 | 0.580 |
Why?
|
| Alginates | 4 | 2014 | 17 | 0.560 |
Why?
|
| Hematopoietic Stem Cells | 6 | 2007 | 327 | 0.560 |
Why?
|
| Neurons | 8 | 2010 | 1653 | 0.560 |
Why?
|
| Primary Myelofibrosis | 4 | 2007 | 68 | 0.550 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2017 | 20 | 0.510 |
Why?
|
| Levodopa | 1 | 2017 | 36 | 0.510 |
Why?
|
| DNA Fragmentation | 3 | 2002 | 65 | 0.480 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 3 | 2012 | 124 | 0.480 |
Why?
|
| Tissue Culture Techniques | 4 | 2014 | 81 | 0.480 |
Why?
|
| Gene Expression | 5 | 2005 | 1320 | 0.470 |
Why?
|
| Extinction, Psychological | 4 | 2015 | 21 | 0.460 |
Why?
|
| Ovary | 3 | 2014 | 268 | 0.450 |
Why?
|
| Genes, fos | 2 | 2006 | 24 | 0.440 |
Why?
|
| Behavior, Animal | 4 | 2007 | 394 | 0.440 |
Why?
|
| Drug-Seeking Behavior | 1 | 2014 | 12 | 0.430 |
Why?
|
| Reward | 5 | 2021 | 209 | 0.430 |
Why?
|
| Mice, Knockout | 12 | 2017 | 2161 | 0.420 |
Why?
|
| Cues | 3 | 2013 | 189 | 0.400 |
Why?
|
| Conditioning, Operant | 3 | 2013 | 68 | 0.390 |
Why?
|
| Dopamine Agonists | 8 | 2009 | 27 | 0.390 |
Why?
|
| Signal Transduction | 8 | 2013 | 3581 | 0.370 |
Why?
|
| Mice, Inbred C57BL | 16 | 2018 | 3489 | 0.360 |
Why?
|
| Gene Expression Regulation | 8 | 2013 | 2061 | 0.350 |
Why?
|
| Dopamine | 8 | 2021 | 283 | 0.350 |
Why?
|
| Cell Movement | 3 | 2007 | 816 | 0.350 |
Why?
|
| Fertility | 1 | 2011 | 119 | 0.350 |
Why?
|
| Self Administration | 3 | 2021 | 76 | 0.340 |
Why?
|
| Infertility, Female | 1 | 2011 | 101 | 0.340 |
Why?
|
| Excitatory Amino Acid Agonists | 2 | 2007 | 45 | 0.320 |
Why?
|
| Apoptosis | 6 | 2017 | 1756 | 0.310 |
Why?
|
| Oogenesis | 1 | 2009 | 47 | 0.300 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2009 | 29 | 0.300 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2007 | 224 | 0.300 |
Why?
|
| Blotting, Western | 6 | 2017 | 796 | 0.300 |
Why?
|
| Motor Activity | 4 | 2007 | 332 | 0.300 |
Why?
|
| Oncogene Proteins v-fos | 1 | 2008 | 3 | 0.290 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2009 | 83 | 0.290 |
Why?
|
| Drug Compounding | 1 | 2009 | 88 | 0.280 |
Why?
|
| Brain | 4 | 2010 | 2482 | 0.270 |
Why?
|
| Proteins | 4 | 2005 | 816 | 0.270 |
Why?
|
| Primates | 1 | 2009 | 160 | 0.270 |
Why?
|
| N-Methylaspartate | 1 | 2007 | 50 | 0.270 |
Why?
|
| Learning | 1 | 2010 | 305 | 0.270 |
Why?
|
| Plant Extracts | 2 | 2020 | 248 | 0.270 |
Why?
|
| Benzazepines | 5 | 2014 | 65 | 0.260 |
Why?
|
| Polycythemia Vera | 2 | 2007 | 23 | 0.260 |
Why?
|
| Hippocampus | 3 | 2012 | 459 | 0.260 |
Why?
|
| Amphetamine | 4 | 2009 | 102 | 0.260 |
Why?
|
| Putamen | 4 | 2010 | 14 | 0.250 |
Why?
|
| Janus Kinase 2 | 1 | 2006 | 59 | 0.240 |
Why?
|
| Caudate Nucleus | 4 | 2007 | 16 | 0.230 |
Why?
|
| Female | 24 | 2017 | 50028 | 0.220 |
Why?
|
| Peptide Hydrolases | 1 | 2005 | 100 | 0.220 |
Why?
|
| Spatial Behavior | 2 | 2012 | 20 | 0.220 |
Why?
|
| Intracellular Fluid | 1 | 2004 | 34 | 0.210 |
Why?
|
| Enzyme Activation | 4 | 2010 | 692 | 0.210 |
Why?
|
| Mice, Transgenic | 7 | 2017 | 1645 | 0.200 |
Why?
|
| Hematopoiesis | 1 | 2004 | 183 | 0.200 |
Why?
|
| Antigens, CD34 | 5 | 2007 | 163 | 0.200 |
Why?
|
| Bone Marrow Cells | 1 | 2004 | 279 | 0.200 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2020 | 590 | 0.190 |
Why?
|
| Male | 22 | 2020 | 45863 | 0.170 |
Why?
|
| Butyrylcholinesterase | 1 | 2021 | 12 | 0.170 |
Why?
|
| Hexuronic Acids | 3 | 2009 | 10 | 0.170 |
Why?
|
| Glucuronic Acid | 3 | 2009 | 11 | 0.170 |
Why?
|
| Immunoglobulin kappa-Chains | 4 | 1989 | 94 | 0.170 |
Why?
|
| Dynorphins | 2 | 2005 | 14 | 0.170 |
Why?
|
| Brain Chemistry | 3 | 2007 | 120 | 0.160 |
Why?
|
| Cell Survival | 3 | 2009 | 1030 | 0.160 |
Why?
|
| Fibrin | 2 | 2011 | 87 | 0.160 |
Why?
|
| Mutation | 5 | 2007 | 4374 | 0.160 |
Why?
|
| Oplopanax | 1 | 2020 | 29 | 0.160 |
Why?
|
| Stem Cells | 2 | 2021 | 394 | 0.150 |
Why?
|
| Androstenedione | 2 | 2009 | 29 | 0.150 |
Why?
|
| Cell Proliferation | 4 | 2017 | 1753 | 0.150 |
Why?
|
| Dopamine Antagonists | 4 | 2007 | 34 | 0.150 |
Why?
|
| Drug Administration Schedule | 3 | 2007 | 873 | 0.150 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2010 | 126 | 0.140 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2010 | 113 | 0.140 |
Why?
|
| Chromatin | 5 | 2007 | 450 | 0.140 |
Why?
|
| Cell Culture Techniques | 2 | 2009 | 197 | 0.140 |
Why?
|
| Estradiol | 2 | 2009 | 255 | 0.140 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 1267 | 0.140 |
Why?
|
| Neoplasms | 2 | 2014 | 3248 | 0.140 |
Why?
|
| Rats | 4 | 2021 | 4155 | 0.140 |
Why?
|
| Glutamic Acid | 2 | 2009 | 159 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2011 | 403 | 0.130 |
Why?
|
| Genes, abl | 1 | 2017 | 12 | 0.130 |
Why?
|
| Abdominal Pain | 1 | 2018 | 145 | 0.130 |
Why?
|
| Cells, Cultured | 7 | 2014 | 2939 | 0.130 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2017 | 17 | 0.130 |
Why?
|
| DNA Primers | 4 | 2006 | 548 | 0.130 |
Why?
|
| Parkinsonian Disorders | 1 | 2017 | 22 | 0.130 |
Why?
|
| Imatinib Mesylate | 1 | 2017 | 127 | 0.130 |
Why?
|
| Panax | 1 | 2018 | 171 | 0.130 |
Why?
|
| Hydroxamic Acids | 2 | 2007 | 52 | 0.120 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2012 | 677 | 0.120 |
Why?
|
| Matrix Metalloproteinase 9 | 2 | 2007 | 84 | 0.120 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2017 | 176 | 0.120 |
Why?
|
| Azacitidine | 2 | 2007 | 150 | 0.120 |
Why?
|
| Reinforcement Schedule | 1 | 2015 | 16 | 0.120 |
Why?
|
| Colitis | 1 | 2018 | 262 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 4 | 2006 | 930 | 0.120 |
Why?
|
| Hyperkinesis | 1 | 1994 | 15 | 0.110 |
Why?
|
| Pyridines | 2 | 2014 | 319 | 0.110 |
Why?
|
| Graft Survival | 2 | 2011 | 942 | 0.110 |
Why?
|
| Immunohistochemistry | 4 | 2005 | 1828 | 0.110 |
Why?
|
| Humans | 21 | 2020 | 96105 | 0.110 |
Why?
|
| Polycythemia | 1 | 2013 | 8 | 0.100 |
Why?
|
| Benzamides | 1 | 2014 | 248 | 0.100 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2013 | 22 | 0.100 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2017 | 644 | 0.100 |
Why?
|
| alpha-Crystallin B Chain | 1 | 2012 | 3 | 0.100 |
Why?
|
| CREB-Binding Protein | 1 | 2012 | 16 | 0.100 |
Why?
|
| Hydrogels | 2 | 2014 | 91 | 0.100 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2017 | 611 | 0.100 |
Why?
|
| Mental Recall | 1 | 2014 | 173 | 0.100 |
Why?
|
| Iron | 1 | 2013 | 179 | 0.100 |
Why?
|
| RNA, Long Noncoding | 1 | 2014 | 130 | 0.100 |
Why?
|
| Feeding Behavior | 1 | 2015 | 338 | 0.090 |
Why?
|
| Genes, Immunoglobulin | 2 | 1989 | 111 | 0.090 |
Why?
|
| Polar Bodies | 1 | 2012 | 2 | 0.090 |
Why?
|
| Brain-Derived Neurotrophic Factor | 2 | 2002 | 31 | 0.090 |
Why?
|
| Reference Values | 2 | 2006 | 674 | 0.090 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 170 | 0.090 |
Why?
|
| Astrocytes | 1 | 2012 | 151 | 0.090 |
Why?
|
| Embryonic and Fetal Development | 2 | 2003 | 71 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 182 | 0.090 |
Why?
|
| Introns | 2 | 1989 | 304 | 0.090 |
Why?
|
| Fertilization | 1 | 2011 | 41 | 0.090 |
Why?
|
| Immobilized Proteins | 1 | 2011 | 15 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 322 | 0.090 |
Why?
|
| Proprotein Convertase 5 | 1 | 2011 | 1 | 0.090 |
Why?
|
| Inhibin-beta Subunits | 1 | 2011 | 3 | 0.090 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2011 | 106 | 0.090 |
Why?
|
| Neuronal Plasticity | 2 | 2009 | 205 | 0.090 |
Why?
|
| Methamphetamine | 1 | 2012 | 104 | 0.090 |
Why?
|
| Inhibins | 1 | 2011 | 34 | 0.090 |
Why?
|
| Prefrontal Cortex | 1 | 2012 | 150 | 0.090 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 2010 | 8 | 0.090 |
Why?
|
| Embryo Culture Techniques | 1 | 2010 | 9 | 0.090 |
Why?
|
| Luteal Phase | 1 | 2010 | 14 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 465 | 0.080 |
Why?
|
| Mice, Inbred Strains | 3 | 2000 | 297 | 0.080 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2010 | 147 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2007 | 908 | 0.080 |
Why?
|
| Papio | 1 | 2010 | 87 | 0.080 |
Why?
|
| Enhancer Elements, Genetic | 2 | 1989 | 308 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2001 | 204 | 0.080 |
Why?
|
| Meiosis | 1 | 2010 | 85 | 0.080 |
Why?
|
| Piperidines | 2 | 2009 | 171 | 0.080 |
Why?
|
| Transfection | 4 | 2003 | 908 | 0.080 |
Why?
|
| Cell Enlargement | 1 | 2009 | 5 | 0.080 |
Why?
|
| Models, Animal | 1 | 2010 | 286 | 0.080 |
Why?
|
| Gonadotropins | 1 | 2009 | 34 | 0.080 |
Why?
|
| Dendrites | 1 | 2010 | 104 | 0.080 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2009 | 50 | 0.080 |
Why?
|
| Hardness | 1 | 2009 | 22 | 0.080 |
Why?
|
| Basal Ganglia | 1 | 2009 | 47 | 0.080 |
Why?
|
| Materials Testing | 1 | 2009 | 94 | 0.070 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2009 | 24 | 0.070 |
Why?
|
| Limbic System | 1 | 2009 | 25 | 0.070 |
Why?
|
| Menstrual Cycle | 1 | 2009 | 59 | 0.070 |
Why?
|
| Progesterone | 1 | 2009 | 112 | 0.070 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 2008 | 2 | 0.070 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 128 | 0.070 |
Why?
|
| Phosphorylation | 2 | 2009 | 1157 | 0.070 |
Why?
|
| Biophysics | 1 | 2008 | 157 | 0.070 |
Why?
|
| Culture Media, Conditioned | 2 | 2007 | 103 | 0.070 |
Why?
|
| Base Sequence | 4 | 2003 | 2344 | 0.070 |
Why?
|
| Hypoxia | 1 | 2013 | 681 | 0.070 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2009 | 188 | 0.070 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 2 | 2007 | 169 | 0.070 |
Why?
|
| Dizocilpine Maleate | 1 | 2007 | 12 | 0.070 |
Why?
|
| Extracellular Matrix | 1 | 2009 | 255 | 0.070 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2021 | 396 | 0.070 |
Why?
|
| Mice, Inbred NOD | 2 | 2006 | 215 | 0.070 |
Why?
|
| Patch-Clamp Techniques | 1 | 2008 | 402 | 0.070 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2007 | 36 | 0.070 |
Why?
|
| Mice, SCID | 2 | 2006 | 279 | 0.070 |
Why?
|
| Synaptic Transmission | 1 | 2009 | 233 | 0.070 |
Why?
|
| Tissue Engineering | 1 | 2009 | 202 | 0.070 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2007 | 82 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2014 | 1667 | 0.070 |
Why?
|
| Electric Stimulation | 1 | 2008 | 397 | 0.070 |
Why?
|
| Drug Interactions | 1 | 2007 | 245 | 0.070 |
Why?
|
| Megakaryocytes | 1 | 2007 | 39 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2007 | 311 | 0.070 |
Why?
|
| Aging | 1 | 2012 | 766 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 2 | 2002 | 242 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2011 | 2090 | 0.060 |
Why?
|
| Stress, Physiological | 1 | 2009 | 252 | 0.060 |
Why?
|
| Homozygote | 4 | 2013 | 208 | 0.060 |
Why?
|
| Inflammation | 1 | 2012 | 1063 | 0.060 |
Why?
|
| Macaca mulatta | 1 | 2009 | 485 | 0.060 |
Why?
|
| Synapses | 1 | 2009 | 291 | 0.060 |
Why?
|
| Granulocytes | 1 | 2006 | 41 | 0.060 |
Why?
|
| Habituation, Psychophysiologic | 2 | 1997 | 14 | 0.060 |
Why?
|
| Hypnotics and Sedatives | 1 | 2007 | 142 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2005 | 897 | 0.060 |
Why?
|
| Chimera | 2 | 1997 | 53 | 0.060 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2006 | 18 | 0.060 |
Why?
|
| Crosses, Genetic | 2 | 1997 | 171 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 312 | 0.060 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2007 | 244 | 0.060 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 6 | 1 | 2005 | 2 | 0.060 |
Why?
|
| Cyclin D | 1 | 2005 | 15 | 0.060 |
Why?
|
| CD2 Antigens | 1 | 2005 | 22 | 0.060 |
Why?
|
| RGS Proteins | 1 | 2005 | 19 | 0.060 |
Why?
|
| Microarray Analysis | 1 | 2005 | 98 | 0.060 |
Why?
|
| Cyclins | 1 | 2005 | 80 | 0.060 |
Why?
|
| Transcription, Genetic | 2 | 1989 | 1192 | 0.060 |
Why?
|
| Amino Acid Substitution | 1 | 2006 | 336 | 0.060 |
Why?
|
| Leukocyte Elastase | 1 | 2005 | 7 | 0.060 |
Why?
|
| Blood Cells | 1 | 2005 | 34 | 0.060 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2005 | 58 | 0.060 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2005 | 48 | 0.060 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2006 | 91 | 0.060 |
Why?
|
| Action Potentials | 1 | 2008 | 618 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 1 | 2007 | 349 | 0.050 |
Why?
|
| Time Factors | 2 | 2005 | 5580 | 0.050 |
Why?
|
| Cloning, Molecular | 3 | 2003 | 648 | 0.050 |
Why?
|
| Behavior, Addictive | 1 | 2006 | 137 | 0.050 |
Why?
|
| Transplantation, Heterologous | 1 | 2006 | 376 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2006 | 481 | 0.050 |
Why?
|
| Clone Cells | 1 | 2004 | 223 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2004 | 226 | 0.050 |
Why?
|
| Electrophysiology | 3 | 2003 | 406 | 0.050 |
Why?
|
| Endodeoxyribonucleases | 1 | 2003 | 16 | 0.050 |
Why?
|
| Receptors, GABA | 1 | 2003 | 11 | 0.050 |
Why?
|
| Chromosome Mapping | 1 | 1986 | 1083 | 0.050 |
Why?
|
| Maze Learning | 1 | 2002 | 32 | 0.050 |
Why?
|
| Adult | 5 | 2020 | 28721 | 0.050 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2002 | 4 | 0.050 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2002 | 11 | 0.050 |
Why?
|
| Genes, Immediate-Early | 1 | 2002 | 18 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-jun | 1 | 2002 | 33 | 0.050 |
Why?
|
| Acute Disease | 1 | 2004 | 872 | 0.050 |
Why?
|
| Leukemia | 1 | 2004 | 328 | 0.050 |
Why?
|
| Receptors, Kainic Acid | 1 | 2002 | 13 | 0.050 |
Why?
|
| Kainic Acid | 1 | 2002 | 23 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2003 | 252 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 701 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2005 | 553 | 0.040 |
Why?
|
| Plasmacytoma | 4 | 1989 | 34 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 1 | 2002 | 227 | 0.040 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2001 | 59 | 0.040 |
Why?
|
| Autophagy-Related Proteins | 1 | 2021 | 24 | 0.040 |
Why?
|
| Cell Death | 1 | 2002 | 264 | 0.040 |
Why?
|
| beta Catenin | 1 | 2002 | 266 | 0.040 |
Why?
|
| Adolescent | 2 | 2014 | 9895 | 0.040 |
Why?
|
| Sesquiterpenes | 1 | 2020 | 13 | 0.040 |
Why?
|
| Biotransformation | 1 | 2020 | 49 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 2418 | 0.040 |
Why?
|
| Models, Genetic | 2 | 2003 | 984 | 0.040 |
Why?
|
| Staurosporine | 1 | 1999 | 34 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2002 | 446 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 206 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2002 | 623 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2020 | 311 | 0.040 |
Why?
|
| Cytokines | 2 | 2018 | 871 | 0.040 |
Why?
|
| Immunity, Innate | 2 | 2013 | 464 | 0.040 |
Why?
|
| Homeostasis | 1 | 2002 | 467 | 0.040 |
Why?
|
| Pregnancy | 3 | 2012 | 3240 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2000 | 284 | 0.040 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2000 | 159 | 0.040 |
Why?
|
| Deoxyribonucleases | 1 | 1998 | 32 | 0.040 |
Why?
|
| Dextran Sulfate | 1 | 2018 | 70 | 0.040 |
Why?
|
| Autoreceptors | 1 | 1998 | 2 | 0.040 |
Why?
|
| Feces | 1 | 2020 | 360 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2001 | 713 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2004 | 943 | 0.030 |
Why?
|
| Ginsenosides | 1 | 2018 | 124 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 1997 | 149 | 0.030 |
Why?
|
| Immune System | 1 | 1998 | 103 | 0.030 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2017 | 41 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2000 | 465 | 0.030 |
Why?
|
| Genotype | 1 | 2002 | 1881 | 0.030 |
Why?
|
| Electroencephalography | 1 | 2002 | 824 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 411 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 299 | 0.030 |
Why?
|
| Neoplasm, Residual | 1 | 2017 | 195 | 0.030 |
Why?
|
| Economics, Behavioral | 1 | 2015 | 7 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2017 | 270 | 0.030 |
Why?
|
| Antipsychotic Agents | 1 | 1996 | 151 | 0.030 |
Why?
|
| Benzopyrans | 2 | 2009 | 12 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2017 | 728 | 0.030 |
Why?
|
| Spiperone | 1 | 1994 | 2 | 0.030 |
Why?
|
| Catalepsy | 1 | 1994 | 3 | 0.030 |
Why?
|
| Anxiety | 1 | 1997 | 339 | 0.030 |
Why?
|
| Food | 1 | 2015 | 93 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 1994 | 147 | 0.030 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2014 | 21 | 0.030 |
Why?
|
| Central Nervous System Stimulants | 1 | 1996 | 235 | 0.030 |
Why?
|
| Interneurons | 1 | 1994 | 106 | 0.030 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2013 | 20 | 0.030 |
Why?
|
| Phlebotomy | 1 | 2013 | 23 | 0.030 |
Why?
|
| Psychomotor Performance | 1 | 1996 | 505 | 0.030 |
Why?
|
| Protein Stability | 1 | 2013 | 106 | 0.020 |
Why?
|
| Quinpirole | 1 | 2012 | 7 | 0.020 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2012 | 10 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 1999 | 1316 | 0.020 |
Why?
|
| Substantia Nigra | 1 | 2012 | 30 | 0.020 |
Why?
|
| Dopaminergic Neurons | 1 | 2012 | 30 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 212 | 0.020 |
Why?
|
| Blastocyst | 1 | 2012 | 35 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 325 | 0.020 |
Why?
|
| Neuroprotective Agents | 1 | 2012 | 102 | 0.020 |
Why?
|
| Microglia | 1 | 2012 | 124 | 0.020 |
Why?
|
| Vitrification | 1 | 2011 | 1 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2003 | 1034 | 0.020 |
Why?
|
| Breeding | 1 | 2011 | 42 | 0.020 |
Why?
|
| Furin | 1 | 2011 | 11 | 0.020 |
Why?
|
| Subtilisins | 1 | 2011 | 27 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2012 | 479 | 0.020 |
Why?
|
| Proprotein Convertases | 1 | 2011 | 27 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 1535 | 0.020 |
Why?
|
| Activins | 1 | 2011 | 26 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2011 | 142 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1994 | 3040 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2011 | 201 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2011 | 368 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 1989 | 65 | 0.020 |
Why?
|
| Dopamine D2 Receptor Antagonists | 1 | 2009 | 7 | 0.020 |
Why?
|
| Dihydroxyphenylalanine | 1 | 2009 | 14 | 0.020 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2009 | 11 | 0.020 |
Why?
|
| Receptors, Dopamine | 1 | 2009 | 37 | 0.020 |
Why?
|
| Mice, Inbred CBA | 1 | 2009 | 52 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2011 | 535 | 0.020 |
Why?
|
| Compressive Strength | 1 | 2009 | 24 | 0.020 |
Why?
|
| Elastic Modulus | 1 | 2009 | 39 | 0.020 |
Why?
|
| Extracellular Space | 1 | 2009 | 90 | 0.020 |
Why?
|
| Miniature Postsynaptic Potentials | 1 | 2009 | 6 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2013 | 873 | 0.020 |
Why?
|
| Hormone Antagonists | 1 | 2009 | 19 | 0.020 |
Why?
|
| Synaptic Membranes | 1 | 2009 | 14 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2009 | 147 | 0.020 |
Why?
|
| Receptors, AMPA | 1 | 2009 | 68 | 0.020 |
Why?
|
| Mifepristone | 1 | 2009 | 51 | 0.020 |
Why?
|
| Pyrroles | 1 | 2009 | 172 | 0.020 |
Why?
|
| Spleen | 1 | 1989 | 439 | 0.020 |
Why?
|
| Mitochondria | 2 | 2003 | 622 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 1346 | 0.020 |
Why?
|
| Cell Line | 2 | 1989 | 2537 | 0.020 |
Why?
|
| Insulin | 1 | 2013 | 1190 | 0.020 |
Why?
|
| Blotting, Southern | 2 | 2003 | 128 | 0.020 |
Why?
|
| Locomotion | 1 | 2009 | 146 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2009 | 309 | 0.020 |
Why?
|
| Calcium Signaling | 1 | 2009 | 142 | 0.020 |
Why?
|
| Indoles | 1 | 2009 | 317 | 0.020 |
Why?
|
| Lymphocytes | 1 | 1989 | 489 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2009 | 333 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2009 | 1010 | 0.020 |
Why?
|
| Thrombopoietin | 1 | 2007 | 12 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2007 | 55 | 0.020 |
Why?
|
| Integrin beta3 | 1 | 2007 | 32 | 0.020 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2007 | 52 | 0.020 |
Why?
|
| Receptors, CXCR4 | 1 | 2007 | 49 | 0.020 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2007 | 61 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 750 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2007 | 149 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 3974 | 0.020 |
Why?
|
| Amines | 1 | 2006 | 31 | 0.020 |
Why?
|
| High Mobility Group Proteins | 1 | 1986 | 27 | 0.020 |
Why?
|
| Thy-1 Antigens | 1 | 2006 | 16 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 1167 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1986 | 180 | 0.020 |
Why?
|
| Nucleosomes | 1 | 1986 | 63 | 0.010 |
Why?
|
| Magnesium | 1 | 2006 | 178 | 0.010 |
Why?
|
| Solubility | 1 | 1986 | 190 | 0.010 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 1986 | 106 | 0.010 |
Why?
|
| Ligands | 1 | 2006 | 478 | 0.010 |
Why?
|
| Spermatogonia | 1 | 2003 | 13 | 0.010 |
Why?
|
| Histones | 1 | 1986 | 363 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 2003 | 76 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2003 | 202 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2012 | 4671 | 0.010 |
Why?
|
| Testis | 1 | 2003 | 153 | 0.010 |
Why?
|
| Middle Aged | 2 | 2017 | 28368 | 0.010 |
Why?
|
| DNA Replication | 1 | 2003 | 177 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2003 | 197 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2003 | 394 | 0.010 |
Why?
|
| Child | 1 | 2014 | 7625 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 223 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2003 | 154 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 2534 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 445 | 0.010 |
Why?
|
| Exons | 1 | 2003 | 454 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 7025 | 0.010 |
Why?
|
| Methylnitronitrosoguanidine | 1 | 2001 | 16 | 0.010 |
Why?
|
| Retina | 1 | 2003 | 219 | 0.010 |
Why?
|
| Cytochrome c Group | 1 | 2001 | 82 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2001 | 164 | 0.010 |
Why?
|
| Caspases | 1 | 2001 | 156 | 0.010 |
Why?
|
| Pain | 1 | 2003 | 426 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 2000 | 70 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2000 | 98 | 0.010 |
Why?
|
| Autoradiography | 1 | 1999 | 69 | 0.010 |
Why?
|
| Oxazines | 1 | 1998 | 15 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 564 | 0.010 |
Why?
|
| Mesencephalon | 1 | 1998 | 69 | 0.010 |
Why?
|
| Haloperidol | 1 | 1996 | 29 | 0.010 |
Why?
|
| ErbB Receptors | 1 | 2000 | 513 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2000 | 463 | 0.010 |
Why?
|
| Gene Deletion | 1 | 1996 | 358 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1989 | 152 | 0.000 |
Why?
|
| Blotting, Northern | 1 | 1989 | 258 | 0.000 |
Why?
|
| Aged | 1 | 2007 | 20968 | 0.000 |
Why?
|
| Plasmids | 1 | 1989 | 291 | 0.000 |
Why?
|
| DNA, Neoplasm | 1 | 1989 | 272 | 0.000 |
Why?
|
| Cell Fractionation | 1 | 1986 | 71 | 0.000 |
Why?
|
| Ubiquitins | 1 | 1986 | 38 | 0.000 |
Why?
|